Maternal asthma in pregnancy and pubertal timing in daughters and sons: A population-based cohort study

Camilla Lomholt Kjersgaard1, Andreas Ernst2, Sofie Aagaard Sand1

  • 1Department of Public Health, Research Unit for Epidemiology, Aarhus University, Bartholins Allé 2, Aarhus 8000, Denmark.

Annals of Epidemiology
|April 18, 2025
PubMed

Insights

Maternal asthma slightly delayed pubertal timing in sons by about one month, but no significant effects were found in daughters. This finding suggests a potential, albeit small, impact of maternal asthma on male pubertal development.

Area of Science:

  • Reproductive Endocrinology
  • Pediatric Health
  • Epidemiology

Background:

  • Maternal asthma prevalence is significant, yet its influence on offspring pubertal timing is not well understood.
  • Puberty is a critical developmental period sensitive to environmental and maternal health factors.

Purpose of the Study:

  • To investigate the association between maternal asthma during pregnancy and the timing of pubertal development in children.
  • To explore potential mediating factors such as birth weight and childhood asthma.

Main Methods:

  • Utilized data from the Danish National Birth Cohort (DNBC) and the Danish National Patient Register.
  • Assessed pubertal timing through half-yearly assessments in the Puberty Cohort, covering Tanner Stages for various developmental milestones.
  • Employed statistical analyses including adjusted mean age differences, negative control, and mediation analyses.

Main Results:

  • Slightly delayed pubertal development observed in sons of mothers with asthma (average 1.0 month difference).
  • No significant associations were found for daughters.
  • Mediation analyses indicated that birth weight and childhood asthma did not explain the observed association in sons.

Conclusions:

  • Maternal asthma during pregnancy is associated with a minor delay in pubertal timing among sons.
  • The observed association in sons is not mediated by birth weight or childhood asthma.
  • The findings suggest a potential, though possibly weak, link between maternal asthma and male pubertal development, warranting further investigation.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
231
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
158
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
148
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
147